You are here


Brand name in Australia, Europe and Latin America for imatinib mesylate, the first generation tyrosine kinase inhibitor used in the treatment of Ph+CML as well as some other cancers; known as Gleevec in Canada, South Africa and the USA.

There is currently no content classified with this term.